Global Antigen Kit Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, And Growth Forecast To 2029

                                          
Global Antigen Kit Market 2021: By technique (Precipitation Reaction, Agglutination Reaction, Complement Fixation, Immunofluorescent Assay, Enzyme-Linked Immunosorbent Assay (ELISA), Other Techniques), By application (Tropical Diseases., Liver Diseases, Autoimmune Diseases, Sexually Transmitted Diseases, Other Diseases), By end-users (Hospitals, Diagnostics Centers, Clinics, Other End-Users)

The Global Antigen Kit market size was valued at USD $4.2 Billion in 2020, USD $4.44 Billion in 2021, forecasted to reach  USD $4.68 Billion in 2022, and is projected to reach USD $7.17 Billion by 2030, and is anticipated to expand at a CAGR of 5.5% over the forecast period from 2020 to 2030.

Global Antigen Kit Market is the title of an upcoming report currently in preparation at Trusted Business Insights. The global antigen kit market report has been segmented on the basis of technique, application, end-user, and regions and countries.

Overview

Antigens are molecules that help the body fight against any infection by stimulating the immune system and activating the white blood cells. There are two major divisions of antigens, namely foreign antigens, which originate outside the body, and the auto-antigens which originate inside the human body. A febrile antigen kit that contains bacterial antigen suspensions that agglutinate (clump) when mixed with human serum containing antibodies against specific pathogens.

Dynamics

Growing demand for antigen kits coupled with increasing prevalence of major diseases such as autoimmune disease and others are among some of the primary factors projected to drive growth of the global antigen kit market over the forecast period. Increasing adoption of antigen kits in a wide range of molecular diagnostics apparatus, medical diagnostics systems, laboratories, and research institutes are among other factors projected to drive growth of the global antigen kit market. In addition, antigen kits are easy to use and convenient for various test and hence, demand for antigen kits has been growing in the recent past. In addition, preference among physicians for such products has been increasing, and this is driving growth of the global antigen kit market to a significant extent. Factors such as quicker and more accurate results of kits without the additional use of any costly apparatus and its effectiveness in evaluating the severity of a persons health and monitoring the treatment also acts as major boost for growth of global antigen kit market.

However, stringent government regulations related to antigen kit approvals are among some of the major factors projected to restrain growth of the global antigen kit market to a certain extent over the forecast period. In addition, tedious process and lack of expertise among technicians could hamper demand in some countries, especially developing economies, during the initial phase of the forecast period.

Increasing investment by major players in R&D activities and increasing global geriatric population are among some major factors projected to create new opportunities for players operating in the global antigen kit market in future.

Segment Analysis

By end-user: Among the end-user segments, the diagnostics center segment is projected to register significantly higher growth in the global antigen kit market owing to easy availability of testing facilities for various antigens.

By application: Among the application segments, revenue from the tropical segment is projected to grow at a significant rate in the global antigen kit market in the coming years. Increasing demand for antigen kits as an ideal testing alternative in developed and developing economies is projected to support revenue growth of this segment in the global antigen kit market over the forecast period.

By technique: Among the technique segments, the enzyme-linked immunosorbent assay (ELISA) segment dominates other segments in the global antigen kit market in terms of revenue share, and the trend is expected to remain steady in the future. Increasing consumer base of health conscious individuals and changing lifestyle are two major factors projected to drive revenue growth of this

segment in the global antigen kit market over the forecast period.

Region Analysis

The North America antigen kit market is projected to account for major revenue share in the global antigen kit market in the coming years. Rising popularity of various antigen kits among physicians in countries in this region is a factor projected to drive growth of the North America market.

Europe is projected to register steady growth in the global market owing to high adoption and demand for various antigen kits in countries in the region.
Markets in Asia Pacific, Latin America, and Middle East & Africa are projected to register moderate growth rates over the forecast period.

Below are the active patents related to Antigen Kit Market.

Patent Number: CN105967233A

Vanadium precipitation method capable of reducing vanadium precipitation wastewater

Abstract

The invention relates to a vanadium precipitation method capable of reducing vanadium precipitation wastewater. The method comprises the following steps: a. carrying out acidic ammonium salt vanadium deposition on a conventional-concentration vanadium solution; b. after finishing adding the ammonium salt in the step a, regulating the pH value and carrying out vanadium precipitation reaction for some time, injecting the high-concentration vanadium solution into the reaction tank; c. adding acid to keep the pH value at 2-3, and continuing holding while stirring; and d. supplementing a certain amount of ammonium salt to continuously react until the precipitation product can not be easily stirred, and filtering to obtain more ammonium vanadate and less vanadium precipitation wastewater. The method provided by the invention can effectively lower the wastewater quantity, and has the advantages of simple technique, high vanadium precipitation rate and high product purity.

Type: Grant

Filed: 2016-07-15

Date of Patent: 2017-07-04

Assignee : Pangang Group Panzhihua Iron and Steel Research Institute Co Ltd

Patent Number: EP2720041A1

Agglutination enhancer

Abstract

The purpose of the present invention is to provide an agglutination enhancer which shows superior agglutination enhancing effect to those of conventional immunoagglutination enhancers, and the present invention relates to an agglutination enhancer for an immunoagglutination measurement method which comprises a polymer having a monomer unit shown by the following general formula [1]:
Figure imga0001

(Wherein R1 represents a hydrogen atom or a methyl group; R2 and R3 independently represent a methyl group or an ethyl group, respectively; X represents -NH- or an oxygen atom; n represents an integer of 1 to 6; and m represents an integer of 1 to 3), and an immunoagglutination measurement method in which, in the coexistence of the above-described agglutination enhancer for immunoagglutination measurement method, an antibody against analyte or an antigen for the analyte is brought into contact with the analyte to cause an antigen-antibody reaction.

Type: Grant

Filed: 2012-06-04

Date of Patent: 2014-04-16

Assignee: Fujifilm Wako Pure Chemical Corp

Patent Number: US8835606B2

Anti-cancer antibodies with reduced complement fixation

Abstract

The invention provides modified antibodies directed against GD2 that have diminished complement fixation relative to antibody-dependent, cell-mediated cytotoxicity, which is maintained. The modified antibodies of the invention may be used in the treatment of tumors such as neuroblastoma, glioblastoma, melanoma, small-cell lung carcinoma, B-cell lymphoma, renal carcinoma, retinoblastoma, and other cancers of neuroectodermal origin

Type: Grant

Filed: 2008-09-12

Date of Patent: 2014-09-16

Assignee : Merck Patent GmbH

Patent Number: CA2553883C

Anti-cancer antibodies with reduced complement fixation

Abstract

The invention provides modified antibodies directed against GD2 that have diminished complement fixation relative to antibody-dependent, cell-mediated cytotoxicity, which is maintained. The modified antibodies of the invention may be used in the treatment of tumors such as neuroblastoma, glioblastoma, melanoma, small-cell lung carcinoma, B-cell lymphoma, renal carcinoma, retinoblastoma, and other cancers of neuroectodermal origin.

Type: Grant

Filed: 2005-01-18

Date of Patent: 2013-04-02

Assignee :  Merck Patent GmbH

Patent Number: US7432357B2

Anti-cancer antibodies with reduced complement fixation

Abstract

The invention provides modified antibodies directed against GD2 that have diminished complement fixation relative to antibody-dependent, cell-mediated cytotoxicity, which is maintained. The modified antibodies of the invention may be used in the treatment of tumors such as neuroblastoma, glioblastoma, melanoma, small-cell lung carcinoma, B-cell lymphoma, renal carcinoma, retinoblastoma, and other cancers of neuroectodermal origin.

Type: Grant

Filed: 2005-01-21

Date of Patent: 2008-10-07

Assignee : Merck Patent GmbH

Below are the leading companies profiled in this Antigen Kit Market Report:

  
Abbott
  
Access Bio., Inc.
  
ADS biotech Inc.
  
Affinity Biologicals Inc.
  
Becton, Dickinson, and Company
  
Cell Biolabs, Inc.
  
Diasorin S.P.A
  
Epitope Diagnostics Inc.
  
F. Hoffmann-La Roche AG
  
GenBody Inc.
  
hermo Fisher Scientific
  
Laboratory Corporation of America
  
Mylab Discovery Solutions Pvt. Ltd
  
Oxford BioMedica.
  
PerkinElmer, Inc.
  
Princeton BioMeditech Corporation
  
Quidel Corporation
  
R-Biopharm AG.
  
SD Biosensor Inc.
  
SinoBiological Inc.
  
Thermo Fisher Scientific

Global Antigen Kit Market Segmentation:

By technique

  
Precipitation Reaction
  
Agglutination Reaction
  
Complement Fixation
  
Immunofluorescent Assay
  
Enzyme-Linked Immunosorbent Assay (ELISA)
  
Other Techniques

By application

  
Tropical Diseases.
  
Liver Diseases
  
Autoimmune Diseases
  
Sexually Transmitted Diseases
  
Other Diseases

By end-users

  
Hospitals
  
Diagnostics Centers
  
Clinics
  
Other End-Users
This research comprehensively answers the following 9 important questions:

  
Q.1. What are some of the most promising growth trends in the Antigen Kit market worldwide?
  
Q.2.Which segments and sub-segments will grow at a faster pace and why? Which segment is nearing the peak and demand saturation?
  
Q.3.Which region will witness a higher growth rate and why? Which region might see a slower or negative growth region?
  
Q.4.What are the key factors affecting market dynamics? What are the drivers, challenges, and business risks in Antigen Kit market?
  
Q.5.What are the business risks and who pose challenges to the global leaders and are competitive threats in this Antigen Kit market?
  
Q.6.What are the emerging trends post COVID-19 reshuffle in this Antigen Kit market and the what are reasons behind these trends and do they translate in global exploration?
  
Q.7. Who are the major global and regional players in the Antigen Kit market? Which are the strategic initiatives key players are pursuing for business growth?
  
Q.8.Which are the competing products in Antigen Kit market and how big of a threat do they pose for loss of market share by material or product substitution?
  
Q.9.What M & A activity has occurred in the last 5 years and what is its impact on the Antigen Kit industry?